Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargine.
Christian OttSusanne JungManuel KornDennis KannenkerilAgnes BoschJulie KolwelterKristina StriepePeter BramlageMario SchifferRoland Erich SchmiederPublished in: Cardiovascular diabetology (2021)
The study was registered at www.clinicaltrials.gov (NCT02752113) on April 26, 2016.